Stocktoria
BIOLIFE SOLUTIONS INC BLFS
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1989-11-22
BIOLIFE SOLUTIONS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $96.2M | $74.6M | $68.0M | $76.2M | $119.2M |
| Gross profit | $62.1M | $50.1M | $41.3M | — | — |
| R&D expense | $7.6M | $4.8M | $5.5M | $8.7M | $11.8M |
| Operating income | -$16.6M | -$4.5M | -$17.2M | -$5.9M | -$35.2M |
| Income tax | $49,000 | -$38,000 | -$64,000 | -$5.2M | -$20.1M |
| Net income | -$4.6M | -$20.2M | -$68.0M | -$139.8M | -$8.9M |
| EPS (diluted) | $-0.10 | $-0.44 | $-1.55 | $-3.25 | $-0.23 |
| Operating cash flow | $20.1M | $8.4M | -$12.5M | -$8.5M | -$4.6M |
| Free cash flow | $10.6M | $5.2M | -$18.9M | -$18.9M | -$13.0M |
| Cash & equivalents | $33.0M | $91.5M | $27.9M | $19.4M | $69.9M |
| Inventory | $30.2M | $29.0M | $27.2M | $34.9M | $28.3M |
| Total assets | $405.9M | $399.5M | $412.7M | $450.2M | $554.3M |
| Total liabilities | $34.0M | $50.6M | $75.1M | $86.0M | $76.2M |
| Shareholders' equity | $371.9M | $348.9M | $337.7M | $364.2M | $478.0M |
Source: SEC EDGAR filings · CIK 0000834365 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.